To build a better VAD: What is needed to make MCS truly competitive with cardiac transplantation for long-term outcomes?

To build a better VAD: What is needed to make MCS truly competitive with cardiac transplantation for long-term outcomes?

While average survival in patients undergoing durable left ventricular assist device (dLVAD) support now approximate 6 years, the application of therapy remains limited across the globe. Herein we highlight important deficiencies common to present technology and propose device innovations and field...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer A. Cowger, MD, MS, Evgenij Potapov, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:JHLT Open
Subjects:
LVAD
Heart failure
Heart transplant
Outcomes
Survival
Adverse events
Online Access:http://www.sciencedirect.com/science/article/pii/S295013342500120X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items